Safety, Tolerability, and Pharmacokinetics of PA9159 Inhalation Aerosol in Healthy Adult Subjects
Clinical trial NCT06916273 · COMPLETED
Trial details
- NCT number
- NCT06916273
- Sponsor
- Anhui Palo Alto Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-22
- Primary completion
- 2024-09-12
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.